|
Tuesday, 02 March 2010 15:29 |
The criteria for release of patients after radionuclide therapy varies widely in different countries. While there is little, if any, difference in scientific aspects as most countries agree on same level of dose for protection of persons involved, the way fears about radiation are handled in different countries has led to variations.
Link to full article on RPOP website
|
|
Tuesday, 02 March 2010 15:27 |
|
In recent months, several media reports have focussed on radiation risks to patients undergoing CT and radiation treatment and have reported cases of over-exposures both in CT and radiotherapy.
Professional societies (AAPM, IOMP, ASTRO) and regulatory bodies (such as FDA) have shown concern. The FDA is launching a new initiative requiring all high-grade medical imaging machines "to include safety controls that prevent patients from receiving excessive radiation doses" and will urge manufacturers to "install safeguards on their machines that automatically notify operators if they are using a higher-than-recommended dose."
The IAEA has a number of actions that contribute to achieving higher levels of safety and reducing the probability of radiation events.
 Link to full article at RPOP |
|
Tuesday, 02 March 2010 15:25 |
IAEA launches project to develop methodologies to track radiation exposure of patients for Radiation SmartCare
Link toarticle at RPOP |
